WallachBeth Capital Starts Thermo Fisher Scientific (TMO) at Buy
Tweet
Share
E-mailGet Alerts TMO Hot Sheet
Price: $588.29 -1.28%
Rating Summary:
34 Buy, 5 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
34 Buy, 5 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
WallachBeth Capital initiates coverage on Thermo Fisher Scientific (NYSE: TMO) with a Buy rating and $68 price target.
Analyst Peter McDonald comments, "TMO's AT business continues to benefit from new product introductions and the Dionex acquisition.TMO’s LPS business should benefit from recent restructuring and consumable demand, but will likely remain constrained given the funding environment. Over the next six months, we see two key headwinds; the uncertainty around academic and government funding (24% of revenue) and the uncertain economy. Its broad customer base helps offset potential academic segmentweakness, and the focus on operational efficiency, new product development, and share repurchases ($750MM) should enhance EPS growth whilea modest valuation (11x 2013e) provides some downside protection."
For an analyst ratings summary and ratings history on Thermo Fisher Scientific click here. For more ratings news on Thermo Fisher Scientific click here.
Shares of Thermo Fisher Scientific closed at $57.15 yesterday.
Analyst Peter McDonald comments, "TMO's AT business continues to benefit from new product introductions and the Dionex acquisition.TMO’s LPS business should benefit from recent restructuring and consumable demand, but will likely remain constrained given the funding environment. Over the next six months, we see two key headwinds; the uncertainty around academic and government funding (24% of revenue) and the uncertain economy. Its broad customer base helps offset potential academic segmentweakness, and the focus on operational efficiency, new product development, and share repurchases ($750MM) should enhance EPS growth whilea modest valuation (11x 2013e) provides some downside protection."
For an analyst ratings summary and ratings history on Thermo Fisher Scientific click here. For more ratings news on Thermo Fisher Scientific click here.
Shares of Thermo Fisher Scientific closed at $57.15 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Thermo Fisher sells microbiology unit to Astorg for $1.075B
- BMO Capital Resumes Snowline Gold Corp (SGD:CN) (SNWGF) at Outperform
- Oppenheimer Starts Carriage Services (CSV) at Outperform
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
